ArticleAIDS and behavior2018

Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States.

D Kerrigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.